Discover
IRWD
Ironwood Pharmaceuticals, Inc.
4.19
9 x 4.19
11 x 4.20
bid
ask
+
0.14
3.56%
01:41 PM
timesize
| Ytd | 24.45% | |
| 1y | 399.30% |
4.08
day range
4.27
0.84
52 week range
5.78
| Open | 4.10 | Prev Close | 4.05 | Low | 4.08 | High | 4.27 | Mkt Cap | 689.86M |
| Vol | 950.93K | Avg Vol | 2.43M | EPS | 0.78 | P/E | 5.37 | Forward P/E | 12.08 |
| Beta | 0.20 | Short Ratio | 6.73 | Inst. Own | 105.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.90 | 200-d Avg | 3.73 | 1yr Est | 12.50 |
| Income Statement | |||
| Total Revenue | 113.04M | ||
| Revenues (USD) | 113.04M | ||
| Gross Profit | 113.04M | ||
| Operating Expenses | 33.73M | ||
| Research and Development Expense | 22.42M | ||
| Selling, General and Administrative Expense | 11.31M | ||
| Operating Income | 79.31M | ||
| Interest Expense | 7.20M | ||
| Income Tax Expense | 22.44M | ||
| Net Income | 51.29M | ||
| Net Income Common Stock | 51.29M | ||
| Net Income Common Stock (USD) | 51.29M | ||
| Consolidated Income | 51.29M | ||
| Earnings per Basic Share | 0.31 | ||
| Earnings per Basic Share (USD) | 0.31 | ||
| Earnings per Diluted Share | 0.31 | ||
| Earning Before Interest & Taxes (EBIT) | 80.93M | ||
| Earning Before Interest & Taxes (USD) | 80.93M | ||
| Weighted Average Shares | 164.41M | ||
| Weighted Average Shares Diluted | 167.18M | ||
| Balance Sheet | |||
| Cash and Equivalents | 79.13M | ||
| Cash and Equivalents (USD) | 79.13M | ||
| Trade and Non-Trade Receivables | 112.73M | ||
| Current Assets | 199.20M | ||
| Property, Plant & Equipment Net | 11.36M | ||
| Total Assets | 285.13M | ||
| Debt Current | 3.29M | ||
| Total Debt | 396.87M | ||
| Current Liabilities | 32.85M | ||
| Debt Non-Current | 393.58M | ||
| Total Liabilities | 446.97M | ||
| Accumulated Retained Earnings (Deficit) | -1.58B | ||
| Accumulated Other Comprehensive Income | -324.00K | ||
| Shareholders Equity | -161.84M | ||
| Shareholders Equity (USD) | -161.84M | ||
| Assets Non-Current | 85.93M | ||
| Total Debt (USD) | 396.87M | ||
| Goodwill and Intangible Assets | 1.63M | ||
| Liabilities Non-Current | 414.12M | ||
| Trade and Non-Trade Payables | 911.00K | ||
| Tax Assets | 69.06M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 910.00K | ||
| Net Cash Flow from Financing | -199.70M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -141.34M | ||
| Issuance (Purchase) of Equity Shares | 303.00K | ||
| Issuance (Repayment) of Debt Securities | -200.00M | ||
| Net Cash Flow from Operations | 58.28M | ||
| Effect of Exchange Rate Changes on Cash | 77.00K | ||
| Share Based Compensation | 3.24M | ||